Vimarsana
Biggest News Aggregation in the World

Jun Gong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jun Gong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jun Gong Today - Breaking & Trending Today

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm - Vimarsana News

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.

Health Equity and Access Weekly Roundup: February 24, 2024 - Vimarsana News

Health Equity and Access Weekly Roundup: February 24, 2024

This week's news from the Center on Health Equity and Access discusses racial disparities in prostate cancer outcomes, the impact of access to cancer care on racial gaps in CLL/SLL outcomes, the effects of 340B programs on drug pricing and health care disparities, the role of mental illness in maternal mortality rates, and racial bias and diagnosis disparities in bipolar disorder.

Source: ajmc.com
Dr Gong on the EMBARK Trial Investigating Enzalutamide in nmCSPC - Vimarsana News

Dr Gong on the EMBARK Trial Investigating Enzalutamide in nmCSPC

Jun Gong, MD, discusses the significance of the phase 3 EMBARK study of enzalutamide in nonmetastatic castration-sensitive prostate cancer.

Dr Jun Gong: Improved Access Closes the Gaps Between Black, White Men With Prostate Cancer - Vimarsana News

Dr Jun Gong: Improved Access Closes the Gaps Between Black, White Men With Prostate Cancer

Despite socioeconomic and biological differences that contribute to disparities between Black men and White men with prostate cancer, improved access has been shown to reduce the gaps, explained Jun Gong, MD, of Cedars Sinai.

Source: ajmc.com
Dr Gong on the Current Treatment Armamentarium in mHSPC - Vimarsana News

Dr Gong on the Current Treatment Armamentarium in mHSPC

Jun Gong, MD, discusses the current treatment armamentarium for patients with metastatic hormone-sensitive prostate cancer.